Evidence map›Paper›PMID 39553359›Full record

ArticleMaedica2024

COVID-19 among Physically Active and Physically Inactive Individuals.

Medala Kalpana, Roja Katta, Umesh Madhusudhan, Archana Gaur, Vidya Ganji, Madhuri Taranikanti, John Nitin, Vasanth Kumar Kasturi

Abstract readEditorial
In one paragraph

Article in Maedica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Medala KalpanaAssociate Professor, Department of Physiology, AIIMS Bibinagar, Hyderabad, Telangana, India.
Roja KattaAssistant Professor, CMR Institute of Medical Sciences, Hyderabad, India.
Umesh MadhusudhanAssistant Professor, Department of Physiology, AIIMS Bibinagar, Hyderabad, Telangana, India.
Archana GaurAssistant Professor, Department of Physiology, AIIMS Bibinagar, Hyderabad, Telangana, India.
Vidya GanjiAssistant Professor, Department of Physiology, AIIMS Bibinagar, Hyderabad, Telangana, India.
Madhuri TaranikantiAdditional Professor, Department of Physiology, AIIMS Bibinagar, Hyderabad, Telangana, India.
John NitinProfessor and Head, Department of Physiology, AIIMS Bibinagar, Hyderabad, Telangana, India.
Vasanth Kumar KasturiTutor, College of Nursing, AIIMS Bibinagar, Hyderabad, Telangana, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCOVID-19 was first reported in Wuhan, China, and subsequently spread worldwide. There were numerous restrictions on daily life activities, including lifestyles, social distancing, isolation and access to many forms of exercise and home confinement. All these activities have health benefits, as they enhance the immune system, which is the need of the hour during the COVID-19 pandemic. There is little data regarding the occurrence of COVID-19 among marathon runners, cyclists and yoga practitioners. The aim of the present study was to find the prevalence of COVID-19 among physically active and physically inactive individuals and to compare it among those groups. MATERIAL AND

methodsPhysically active individuals were selected as per the Global Recommendations on Physical Activity for Health 2010, in the age group of 18-60 years, and included runners, yoga practitioners and cyclists from the Hyderabad club. A prevalidated questionnaire was circulated among the study groups through Google form. The data was analyzed statistically.

resultsThere was a high proportion of persons affected by COVID-19 in the physically inactive group (75.75%) when compared to the active group (17.17%). The percentages of subjects who tested positive for COVID-19 were as follows: 16.16% cyclists, 29.29% runners and 27.27% yoga practitioners among the physically active individuals, and 51.51% of physically inactive subjects.

conclusionPhysical activity acts as a barrier against COVID-19 infections and enhances the immune system. Therefore, it has to be prioritized by public health agencies and incorporated into routine medical care.

Identifiers

PMID39553359
PMCPMC11565149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.